REQUIP®
(ropinirole) tablets
If you have Restless Legs Syndrome (RLS, also known as Ekbom Syndrome),
read this portion.
Read this information completely before you start taking REQUIP (ropinirole hcl) . Read
the information each time you get more medicine. There may be new information.
This leaflet provides a summary about REQUIP (ropinirole hcl) . It does not include everything
there is to know about your medicine. This information should not take the place
of discussions with your doctor about your medical condition or REQUIP (ropinirole hcl) .
What is REQUIP (ropinirole hcl) ?
REQUIP (ropinirole hcl) is a prescription medicine to treat moderate-to-severe primary Restless
Legs Syndrome. It is sometimes used to treat Parkinson's disease. Having one
of these conditions does not mean you have or will develop the other.
What is the most important information I should know about REQUIP (ropinirole hcl) ?
- Patients with RLS should take REQUIP (ropinirole hcl) differently than patients with Parkinson's
disease (see How should I take REQUIP (ropinirole hcl) for RLS? for the recommended
dosing for RLS). A lower dose of REQUIP (ropinirole hcl) is generally needed for patients with
RLS, and is taken once daily before bedtime.
- There are known side effects of REQUIP (ropinirole hcl) . If you fall asleep or feel very
sleepy while doing normal activities such as driving, faint, feel dizzy, nauseated,
or sweaty when you stand up from sitting or lying down, you should talk with
your doctor (see What are the possible side effects of REQUIP (ropinirole hcl) ?).
- Before starting REQUIP (ropinirole hcl) , be sure to tell your doctor if you are taking any
medicines that make you drowsy.
Unusual urges: Some patients taking REQUIP (ropinirole hcl) or REQUIP (ropinirole hcl) XL get urges to
behave in a way unusual for them. Examples of this are an unusual urge to gamble
or increased sexual urges and behaviors. If you notice or your family notices
that you are developing any unusual behaviors, talk to your healthcare provider.
Who should not take REQUIP (ropinirole hcl) ?
You should not take REQUIP if you are allergic to the active ingredient ropinirole
or to any of the inactive ingredients. Your doctor and pharmacist have a list
of the inactive ingredients.
What should I tell my doctor?
Be sure to tell your doctor if:
- you are pregnant or plan to become pregnant.
- you are breastfeeding.
- you have daytime sleepiness from a sleep disorder other than RLS or have
unexpected sleepiness or periods of sleep while taking REQUIP (ropinirole hcl) .
- you are taking any other prescription or over-the-counter medicines. Some
of these medicines may increase your chances of getting side effects while
taking REQUIP (ropinirole hcl) .
- you start or stop taking other medicines while you are taking REQUIP (ropinirole hcl) . This
may increase your chances of getting side effects.
- you start or stop smoking while you are taking REQUIP (ropinirole hcl) . Smoking may decrease
the treatment effect of REQUIP (ropinirole hcl) .
- you feel dizzy, nauseated, sweaty, or faint when you stand up from sitting
or lying down.
- you drink alcoholic beverages. This may increase your chances of becoming
drowsy or sleepy while taking REQUIP (ropinirole hcl) .
How should I take REQUIP (ropinirole hcl) for RLS?
- Be sure to take REQUIP (ropinirole hcl) exactly as directed by your doctor or healthcare
provider.
- The usual way to take REQUIP (ropinirole hcl) is once in the evening, 1 to 3 hours before
bedtime.
- Your doctor will start you on a low dose of REQUIP (ropinirole hcl) . Your doctor may change
the dose until you are taking the amount of medicine that is right for you
to control your symptoms.
- If you miss your dose, do not double your next dose. Take only your
usual dose 1 to 3 hours before your next bedtime.
- Contact your doctor, if you stop taking REQUIP (ropinirole hcl) for any reason. Do not restart
without consulting your doctor.
- You can take REQUIP (ropinirole hcl) with or without food. Taking REQUIP (ropinirole hcl) with food may decrease
the chances of feeling nauseated.
What are the possible side effects of REQUIP (ropinirole hcl) ?
- Most people who take REQUIP (ropinirole hcl) tolerate it well. The most commonly reported
side effects in people taking REQUIP (ropinirole hcl) for RLS are nausea, vomiting, dizziness,
and drowsiness or sleepiness. You should be careful until you know if REQUIP (ropinirole hcl)
affects your ability to remain alert while doing normal daily activities,
and you should watch for the development of significant daytime sleepiness
or episodes of falling asleep. It is possible that you could fall asleep while
doing normal activities such as driving a car, doing physical tasks, or using
hazardous machinery while taking REQUIP (ropinirole hcl) . Your chances of falling asleep while
doing normal activities while taking REQUIP (ropinirole hcl) are greater if you are taking
other medicines that cause drowsiness.
- When you start taking REQUIP (ropinirole hcl) or when you increase your dose, you may feel
dizzy, nauseated, sweaty or faint, when first standing up from sitting or
lying down. Therefore, do not stand up quickly after sitting or lying down,
particularly if you have been sitting or lying down for a long period of time.
Take a minute sitting on the edge of the bed or chair before you get up.
- Hallucinations (unreal sounds, visions, or sensations) have been reported
in patients taking REQUIP (ropinirole hcl) . These were uncommon in patients taking REQUIP (ropinirole hcl) for
RLS. The risk is greater in patients with Parkinson's disease who are elderly,
taking REQUIP (ropinirole hcl) with L-dopa, or taking higher doses of REQUIP (ropinirole hcl) than recommended
for RLS.
Some patients taking REQUIP (ropinirole hcl) get urges to behave in a way unusual for them.
Examples of this are an unusual urge to gamble or increased sexual urges and
behaviors. If you notice or your family notices that you are developing any
unusual behaviors, talk to your healthcare provider.
This is not a complete list of side effects and should not take the place of
discussions with your healthcare providers. Your doctor or pharmacist can give
you a more complete list of possible side effects.
Call your healthcare provider for medical advice about side effects. You may
report side effects to FDA at 1-800-FDA-1088.
Other Information about REQUIP (ropinirole hcl)
- Studies of people with Parkinson's disease show that they may be at an increased
risk of developing melanoma, a form of skin cancer, when compared to people
without Parkinson's disease. It is not known if this problem is associated
with Parkinson's disease or the medicines used to treat Parkinson's disease.
REQUIP (ropinirole hcl) is one of the medicines used to treat Parkinson's disease, therefore,
patients being treated with REQUIP (ropinirole hcl) should have periodic skin examinations.
- Take REQUIP (ropinirole hcl) exactly as your doctor prescribes it.
- Do not share REQUIP (ropinirole hcl) with other people, even if they have the same symptoms
you have.
- Keep REQUIP (ropinirole hcl) out of the reach of children.
- Store REQUIP (ropinirole hcl) at room temperature out of direct sunlight.
- Keep REQUIP (ropinirole hcl) in a tightly closed container.
This leaflet summarizes important information about REQUIP (ropinirole hcl) . Medicines are sometimes
prescribed for purposes other than those listed in this leaflet. Do not take
REQUIP (ropinirole hcl) for a condition for which it was not prescribed. For more information,
talk with your doctor or pharmacist. They can give you information about REQUIP (ropinirole hcl)
that is written for healthcare professionals.
PATIENT INFORMATION
REQUIP®
(ropinirole) tablets
If you have Parkinson's disease, read the following:
Read this information completely before you start taking REQUIP (ropinirole hcl) . Read
the information each time you get more medicine. There may be new information.
This leaflet provides a summary about REQUIP (ropinirole hcl) . It does not include everything
there is to know about your medicine. This information should not take the place
of discussions with your doctor about your medical condition or REQUIP (ropinirole hcl) .
What is REQUIP (ropinirole hcl) ?
REQUIP (ropinirole hcl) is a prescription medicine used to treat Parkinson's disease. It is
also used to treat moderate-to-severe primary Restless Legs Syndrome. Having
one of these conditions does not mean you have or will develop the other.
What is the most important information I should know about REQUIP (ropinirole hcl) ?
- Patients with Parkinson's disease should take REQUIP (ropinirole hcl) differently than patients
with Restless Legs Syndrome (see How should I take REQUIP (ropinirole hcl) for Parkinson's
disease?). For Parkinson's disease, a higher dose of REQUIP (ropinirole hcl) is generally
needed, and is taken more frequently throughout the day.
- There are known side effects of REQUIP (ropinirole hcl) (see What are the possible side
effects of REQUIP (ropinirole hcl) ?).
- If you fall asleep or feel very sleepy while doing normal activities such
as driving, faint, feel dizzy, nauseated, or sweaty when you stand up from
sitting or lying down, you should talk with your doctor.
- Hallucinations (unreal visions, sounds, or sensations) have been reported
in patients taking REQUIP (ropinirole hcl) . The risk is greater in patients with Parkinson's
disease who are elderly, taking REQUIP (ropinirole hcl) with L-dopa or taking higher doses
of REQUIP (ropinirole hcl) . If these occur, you should discuss them with your doctor.
- REQUIP (ropinirole hcl) may make some of the side effects of L-dopa worse. REQUIP (ropinirole hcl) may cause
uncontrolled sudden movements or make such movements you already have worse
or more frequent. You should notify your doctor in such a case as dosage adjustments
to your anti-Parkinson's medications may be necessary.
- Before starting REQUIP (ropinirole hcl) , be sure to tell your doctor if you are taking any
medicines that make you drowsy.
Unusual urges: Some patients taking REQUIP (ropinirole hcl) or REQUIP (ropinirole hcl) XL get urges to
behave in a way unusual for them. Examples of this are an unusual urge to gamble
or increased sexual urges and behaviors. If you notice or your family notices
that you are developing any unusual behaviors, talk to your healthcare provider.
Who should not take REQUIP (ropinirole hcl) ?
You should not take REQUIP if you are allergic to the active ingredient ropinirole
or to any of the inactive ingredients. Your doctor and pharmacist have a list
of the inactive ingredients.
What should I tell my doctor?
Be sure to tell your doctor if:
- you are pregnant or plan to become pregnant.
- you are breastfeeding.
- you have daytime sleepiness from a sleep disorder or have unexpected sleepiness
or periods of sleep while taking REQUIP (ropinirole hcl) .
- you are taking any other prescription or over-the-counter medicines. Some
of these medicines may increase your chances of getting side effects while
taking REQUIP (ropinirole hcl) .
- you start or stop taking other medicines while you are taking REQUIP (ropinirole hcl) . This
may increase your chances of getting side effects.
- you start or stop smoking while you are taking REQUIP (ropinirole hcl) . Smoking may decrease
the treatment effect of REQUIP (ropinirole hcl) .
- you feel dizzy, nauseated, sweaty, or faint when you first stand up from
sitting or lying down.
- you drink alcoholic beverages. This may increase your chances of becoming
drowsy or sleepy while taking REQUIP (ropinirole hcl) .
How should I take REQUIP (ropinirole hcl) for Parkinson's disease?
- Be sure to take your REQUIP (ropinirole hcl) exactly as directed by your doctor or healthcare
provider.
- Three times a day is the usual way to take REQUIP (ropinirole hcl) for Parkinson's disease.
- Your doctor will start you on a low dose of REQUIP (ropinirole hcl) . Your doctor will change
the dose until you are taking the right amount of medicine to control your
symptoms. It may take several weeks before you reach a dose that controls
your symptoms.
- If you miss a dose, do not double your next dose.
- Contact your doctor, if you stop taking REQUIP (ropinirole hcl) for any reason. Do not restart
without consulting your doctor.
- Your doctor may prescribe REQUIP (ropinirole hcl) alone or add REQUIP (ropinirole hcl) to medicine that you
are already taking for Parkinson's disease.
- You can take REQUIP (ropinirole hcl) with or without food. Taking REQUIP (ropinirole hcl) with food may decrease
the chances of feeling nauseated.
What are the possible side effects of REQUIP (ropinirole hcl) ?
- Most people who take REQUIP (ropinirole hcl) tolerate it well. The most commonly reported
side effects in people taking REQUIP (ropinirole hcl) are nausea, headache, dizziness, drowsiness
or sleepiness.
- You should be careful until you know if REQUIP (ropinirole hcl) affects your ability to remain
alert while doing normal daily activities, and you should watch for the development
of significant daytime sleepiness or episodes of falling asleep. It is possible
that you could fall asleep while doing normal activities such as driving a
car, doing physical tasks, or using hazardous machinery while taking REQUIP (ropinirole hcl) .
Your chances of falling asleep while doing normal activities while taking
REQUIP (ropinirole hcl) are greater if you are taking other medicines that cause drowsiness.
- When you start taking REQUIP (ropinirole hcl) or when you increase your dose, you may feel
dizzy, nauseated, sweaty or faint, when first standing up from sitting or
lying down. Therefore, do not stand up quickly after sitting or lying down,
particularly if you have been sitting or lying down for a long period of time.
Take a minute sitting on the edge of the bed or chair before you get up.
- Hallucinations (unreal visions, sounds, or sensations) have been reported
in patients taking REQUIP (ropinirole hcl) . The risk is greater in patients with Parkinson's
disease who are elderly, taking REQUIP (ropinirole hcl) with L-dopa, or taking higher amounts
of REQUIP (ropinirole hcl) .
- If you are taking L-dopa for Parkinson's disease, REQUIP (ropinirole hcl) may make some of
the side effects of L-dopa worse. REQUIP (ropinirole hcl) may cause uncontrolled sudden movements
or make such movements you already have worse or more frequent.
Some patients taking REQUIP (ropinirole hcl) get urges to behave in a way unusual for them.
Examples of this are an unusual urge to gamble or increased sexual urges and
behaviors. If you notice or your family notices that you are developing any
unusual behaviors, talk to your healthcare provider.
This is not a complete list of side effects and should not take the place of
discussions with your healthcare providers. Your doctor or pharmacist can give
you a more complete list of possible side effects.
Call your healthcare provider for medical advice about side effects. You may
report side effects to FDA at 1-800-FDA-1088.
Other Information about REQUIP (ropinirole hcl)
- Studies of people with Parkinson's disease show that they may be at an increased
risk of developing melanoma, a form of skin cancer, when compared to people
without Parkinson's disease. It is not known if this problem is associated
with Parkinson's disease or the medicines used to treat Parkinson's disease,
therefore, patients being treated with REQUIP (ropinirole hcl) should have periodic skin examinations.
- Take REQUIP (ropinirole hcl) exactly as your doctor prescribes it.
- Do not share REQUIP (ropinirole hcl) with other people, even if they have the same symptoms
you have.
- Keep REQUIP (ropinirole hcl) out of the reach of children.
- Store REQUIP (ropinirole hcl) at room temperature out of direct sunlight.
- Keep REQUIP (ropinirole hcl) in a tightly closed container.
This leaflet summarizes important information about REQUIP (ropinirole hcl) . Medicines are sometimes
prescribed for purposes other than those listed in this leaflet. Do not take
REQUIP (ropinirole hcl) for a condition for which it was not prescribed. For more information,
talk with your doctor or pharmacist. They can give you information about REQUIP (ropinirole hcl)
that is written for healthcare professionals.
Last reviewed on RxList: 11/30/2010
This monograph has been modified to include the generic and brand name in many instances.